Page last updated: 2024-11-03

prazosin and Tetralogy of Fallot

prazosin has been researched along with Tetralogy of Fallot in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Tetralogy of Fallot: A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borthne, K1
Hågå, P1
Langslet, A1
Lindberg, H1
Skomedal, T1
Osnes, JB1

Other Studies

1 other study available for prazosin and Tetralogy of Fallot

ArticleYear
Endogenous norepinephrine stimulates both alpha 1- and beta-adrenoceptors in myocardium from children with congenital heart defects.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:1

    Topics: Child; Child, Preschool; Female; Heart Atria; Heart Defects, Congenital; Heart Ventricles; Humans; I

1995